Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New bedside heart test could slash ER wait times for chest pain

NCT ID NCT06899776

Knowledge-focused Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This study looks at whether a quick, point-of-care blood test for heart damage can give results faster than standard lab tests for people with chest pain in the emergency room. Researchers will compare the time it takes to get test results and how long patients stay in the ER. The goal is to see if this faster test can improve patient flow and hospital revenue without compromising care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults (≥18 years old) presenting to the ED with symptoms concerning for acute coronary syndrome (ACS) and an ECG and troponin ordered as part of standard of care, will be eligible for accrual. Patients with STEMI activation or unstable vital signs will be excluded. In addition, patients will be required to have a (extra) lithium heparin blood sample collected within ± 5 minutes of their clinical draw for hs-cTnI. Patients with central laboratory hs-cTnI testing or a hs-cTnI measure resulted prior to study accrual also be excluded.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age greater than or equal to18 years * Symptoms suggestive of acute coronary syndrome: * Acute chest, epigastric, neck, jaw or arm pain or discomfort or pressure without apparent non-cardiac source * Shortness of breath, nausea, vomiting, fatigue/malaise, or * Other equivalent discomfort suggestive of an myocardial infarction (MI) * Electrocardiogram (ECG) ordered as part of standard of care * At least one troponin collected as standard of care * Study specific blood sample collected within ± 5 minutes of clinical draw Exclusion Criteria: * ST-segment elevation myocardial infarction (STEMI) Activation * Unstable vitals signs: symptomatic hypotension at the time of enrollment (systolic \< 90 mm Hg), tachycardia (HR\>120), bradycardia (HR\<40), and hypoxemia (\<90% pulse-oximetry on room air or normal home oxygen flow rate) * Central laboratory hs-cTn testing resulted or in process (\>5 minutes) prior to study accrual * Prior enrollment * Terminal diagnosis with life expectancy less than 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acs (acute coronary syndrome) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute chest syndrome acute coronary syndrome Chest Pain Emergencies myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acs (acute coronary syndrome)

Contacts and locations

Locations

  • Carolinas Medical Center

    Charlotte, North Carolina, 28203, United States

  • High Point Medical Center

    High Point, North Carolina, 27262, United States

  • Wake Forest School of Medicine

    Winston-Salem, North Carolina, 27517, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.